Lymph node metastasis (LNM) is the primary metastatic mode in gastric cancer (GC), with frequent occurrences in lesser curvature. This study aims to establish a radiomic model to predict the metastatic status of lymph nodes in the lesser curvature for GC. We retrospectively collected data from 939 gastric cancer patients who underwent gastrectomy and D2 lymphadenectomy across two centers. Both the primary lesion and the lesser curvature region were segmented as representative region of interests (ROIs). The combination of bi-regional and bi-phasic CT imaging features were used to build a hybrid radiomic model to predict LNM in the lesser curvature. And the model was validated internally and externally. Further, the potential generalization ability of the hybrid model was investigated in predicting the metastasis status in the supra-pancreatic area. The hybrid model yielded substantially higher performance with AUCs of 0.847 (95% CI, 0.770-0.924) and 0.833 (95% CI, 0.800-0.867) in the two independent test cohorts, compared to the single regional and phasic models. Additionally, the hybrid model achieved AUCs ranging from 0.678 to 0.761 in the prediction of LNM in supra-pancreatic area, showing the potential generalization performance. The CT imaging features of primary tumor and adjacent tissues are significantly associated with LNM. And our as-developed model showed great diagnostic performance and might be of great application in the individual treatment of GC.

Mandibular reconstruction to restore mandibular continuity often relies on patient-specific implants and virtual surgical planning, but current implant designs rarely consider individual biomechanical demands, which are critical for preventing complications such as stress shielding, screw loosening, and implant failure. The inclusion of patient-specific masticatory muscle parameters such as cross-sectional area, vectors, and volume could improve implant success, but manual segmentation of these parameters is time-consuming, limiting large-scale analyses. In this study, a deep learning model was trained for automatic segmentation of eight masticatory muscles on MRI images. Forty T1-weighted MRI scans were segmented manually or via pseudo-labelling for training. Training employed 5-fold cross-validation over 1000 epochs per fold and testing was done on 10 manually segmented scans. The model achieved a mean Dice similarity coefficient (DSC) of 0.88, intersection over union (IoU) of 0.79, precision of 0.87, and recall of 0.89, demonstrating high segmentation accuracy. These results indicate the feasibility of large-scale, reproducible analyses of muscle volumes, directions, and estimated forces. By integrating these parameters into implant design and surgical planning, this method offers a step forward in developing personalized surgical strategies that could improve postoperative outcomes in mandibular reconstruction. This brings the field closer to truly individualized patient care.

This study compared two uncertainty quantification (UQ) metrics to rule out prostate MRI scans with a high-confidence artificial intelligence (AI) prediction and investigated the resulting potential radiologist's workload reduction in a clinically significant prostate cancer (csPCa) detection pathway. This retrospective study utilized 1612 MRI scans from three institutes for csPCa (Gleason Grade Group ≥ 2) assessment. We compared the standard diagnostic pathway (radiologist reading) to an AI-based rule-out pathway in terms of efficacy and accuracy in diagnosing csPCa. In the rule-out pathway, 15 AI submodels (trained on 7756 cases) diagnosed each MRI scan, and any prediction deemed uncertain was referred to a radiologist for reading. We compared the mean (meanUQ) and variability (varUQ) of predictions using the DeLong test on the area under the receiver operating characteristic curves (AUROC). The level of workload reduction of the best UQ method was determined based on a maintained sensitivity at non-inferior specificity using the margins 0.05 and 0.10. The workload reduction of the proposed pathway was institute-specific: up to 20% at a 0.10 non-inferiority margin (p < 0.05) and non-significant workload reduction at a 0.05 margin. VarUQ-based rule out gave higher but non-significant AUROC scores than meanUQ in certain selected cases (+0.05 AUROC, p > 0.05). MeanUQ and varUQ showed promise in AI-based rule-out csPCa detection. Using varUQ in an AI-based csPCa detection pathway could reduce the number of scans radiologists need to read. The varying performance of the UQ rule-out indicates the need for institute-specific UQ thresholds. Question AI can autonomously assess prostate MRI scans with high certainty at a non-inferior performance compared to radiologists, potentially reducing the workload of radiologists. Findings The optimal ratio of AI-model and radiologist readings is institute-dependent and requires calibration. Clinical relevance Semi-autonomous AI-based prostate cancer detection with variational UQ scores shows promise in reducing the number of scans radiologists need to read.

To assess the technical success of radiofrequency ablation (RFA) in patients with hepatocellular carcinoma (HCC), an artificial intelligence (AI) model was developed to estimate the tumor coverage without the need for segmentation or registration tools. A secondary retrospective analysis of 550 patients in the multicenter and multinational OPTIMA trial (3-7 cm solidary HCC lesions, randomized to RFA or RFA + LTLD) identified 182 patients with well-defined pre-RFA tumor and 1-month post-RFA devascularized ablation zones on enhanced CT. The ground-truth, or percent tumor coverage, was determined based on the result of semi-automatic 3D tumor and ablation zone segmentation and elastic registration. The isocenter of the tumor and ablation was isolated on 2D axial CT images. Feature extraction was performed, and classification and linear regression models were built. Images were augmented, and 728 image pairs were used for training and testing. The estimated percent tumor coverage using the models was compared to ground-truth. Validation was performed on eight patient cases from a separate institution, where RFA was performed, and pre- and post-ablation images were collected. In testing cohorts, the best model accuracy was with classification and moderate data augmentation (AUC = 0.86, TPR = 0.59, and TNR = 0.89, accuracy = 69%) and regression with random forest (RMSE = 12.6%, MAE = 9.8%). Validation in a separate institution did not achieve accuracy greater than random estimation. Visual review of training cases suggests that poor tumor coverage may be a result of atypical ablation zone shrinkage 1 month post-RFA, which may not be reflected in clinical utilization. An AI model that uses 2D images at the center of the tumor and 1 month post-ablation can accurately estimate ablation tumor coverage. In separate validation cohorts, translation could be challenging.

Diffusion-weighted imaging (DWI) is widely applied in tumor diagnosis by measuring the diffusion of water molecules. To increase the sensitivity to tumor identification, faithful high b-value DWI images are expected by setting a stronger strength of gradient field in magnetic resonance imaging (MRI). However, high b-value DWI images are heavily affected by reduced signal-to-noise ratio due to the exponential decay of signal intensity. Thus, removing noise becomes important for high b-value DWI images. Here, we propose a Physics-Informed neural Network for high b-value DWI images Denoising (PIND) by leveraging information from physics-informed loss and prior information from low b-value DWI images with high signal-to-noise ratio. Experiments are conducted on a prostate DWI dataset that has 125 subjects. Compared with the original noisy images, PIND improves the peak signal-to-noise ratio from 31.25 dB to 36.28 dB, and structural similarity index measure from 0.77 to 0.92. Our schemes can save 83% data acquisition time since fewer averages of high b-value DWI images need to be acquired, while maintaining 98% accuracy of the apparent diffusion coefficient value, suggesting its potential effectiveness in preserving essential diffusion characteristics. Reader study by 4 radiologists (3, 6, 13, and 18 years of experience) indicates PIND's promising performance on overall quality, signal-to-noise ratio, artifact suppression, and lesion conspicuity, showing potential for improving clinical DWI applications.

This systematic review and meta-analysis aimed to assess the diagnostic accuracy of radiomics in risk stratification of gastrointestinal stromal tumors (GISTs). It focused on evaluating radiomic models as a non-invasive tool in clinical practice. A comprehensive search was conducted across PubMed, Web of Science, EMBASE, Scopus, and Cochrane Library up to May 17, 2025. Studies involving preoperative imaging and radiomics-based risk stratification of GISTs were included. Quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool and Radiomics Quality Score (RQS). Pooled sensitivity, specificity, and area under the curve (AUC) were calculated using bivariate random-effects models. Meta-regression and subgroup analyses were performed to explore heterogeneity. A total of 29 studies were included, with 22 (76 %) based on computed tomography scans, while 2 (7 %) were based on endoscopic ultrasound, 3 (10 %) on magnetic resonance imaging, and 2 (7 %) on ultrasound. Of these, 18 studies provided sufficient data for meta-analysis. Pooled sensitivity, specificity, and AUC for radiomics-based GIST risk stratification were 0.84, 0.86, and 0.90 for training cohorts, and 0.84, 0.80, and 0.89 for validation cohorts. QUADAS-2 indicated some bias due to insufficient pre-specified thresholds. The mean RQS score was 13.14 ± 3.19. Radiomics holds promise for non-invasive GIST risk stratification, particularly with advanced imaging techniques. However, radiomic models are still in the early stages of clinical adoption. Further research is needed to improve diagnostic accuracy and validate their role alongside conventional methods like biopsy or surgery.

to evaluate the prognostic role of the marker albumin-myosteatosis (MAM) in Caucasian patients with metastatic colorectal cancer. this study involved 55 consecutive Caucasian patients diagnosed with metastatic colorectal cancer. CT scans at the L3 vertebral level were analyzed to determine skeletal muscle cross-sectional area, skeletal muscle index (SMI), and skeletal muscle density (SMD). Bioelectrical impedance analysis (BIA) (phase angle, reactance, resistance, and SMI-BIA) was used. Albumin and prealbumin were measured. The albumin-myosteatosis marker (AMM = serum albumin (g/dL) × skeletal muscle density (SMD) in Hounsfield units (HU) was calculated. Survival was estimated using the Kaplan-Meier method and comparisons between groups were performed using the log-rank test. the median age was 68.1 ± 9.1 years. Patients were divided into two groups based on the median MAM (129.1 AU for women and 156.3 AU for men). Patients in the low MAM group had significantly reduced values of phase angle and reactance, as well as older age. These patients also had higher rates of malnutrition by GLIM criteria (odds ratio: 3.8; 95 % CI = 1.2-12.9), low muscle mass diagnosed with TC (odds ratio: 3.6; 95 % CI = 1.2-10.9) and mortality (odds ratio: 9.82; 95 % CI = 1.2-10.9). The Kaplan-Meir analysis demonstrated significant differences in 5-year survival between MAM groups (patients in the low median MAM group vs. patients in the high median MAM group), (HR: 6.2; 95 % CI = 1.10-37.5). the marker albumin-myosteatosis (MAM) may function as a prognostic marker of survival in Caucasian patients with metastatic CRC.

To facilitate implementation of plan-of-the-day (POTD) selection for treating locally advanced cervical cancer (LACC), we developed a POTD assessment tool for CBCT-guided radiotherapy (RT). A female pelvis segmentation model (U-Seg3) is combined with a quantitative standard operating procedure (qSOP) to identify optimal and acceptable plans. &#xD;&#xD;Approach: The planning CT[i], corresponding structure set[ii], and manually contoured CBCTs[iii] (n=226) from 39 LACC patients treated with POTD (n=11) or non-adaptive RT (n=28) were used to develop U-Seg3, an algorithm incorporating deep-learning and deformable image registration techniques to segment the low-risk clinical target volume (LR-CTV), high-risk CTV (HR-CTV), bladder, rectum, and bowel bag. A single-channel input model (iii only, U-Seg1) was also developed. Contoured CBCTs from the POTD patients were (a) reserved for U-Seg3 validation/testing, (b) audited to determine optimal and acceptable plans, and (c) used to empirically derive a qSOP that maximised classification accuracy. &#xD;&#xD;Main Results: The median [interquartile range] DSC between manual and U-Seg3 contours was 0.83 [0.80], 0.78 [0.13], 0.94 [0.05], 0.86[0.09], and 0.90 [0.05] for the LR-CTV, HR-CTV, bladder, rectum, and bowel bag. These were significantly higher than U-Seg1 in all structures but bladder. The qSOP classified plans as acceptable if they met target coverage thresholds (LR-CTV≧99%, HR-CTV≧99.8%), with lower LR-CTV coverage (≧95%) sometimes allowed. The acceptable plan minimising bowel irradiation was considered optimal unless substantial bladder sparing could be achieved. With U-Seg3 embedded in the qSOP, optimal and acceptable plans were identified in 46/60 and 57/60 cases. &#xD;&#xD;Significance: U-Seg3 outperforms U-Seg1 and all known CBCT-based female pelvis segmentation models. The tool combining U-Seg3 and the qSOP identifies optimal plans with equivalent accuracy as two observers. In an implementation strategy whereby this tool serves as the second observer, plan selection confidence and decision-making time could be improved whilst simultaneously reducing the required number of POTD-trained radiographers by 50%.&#xD;&#xD;&#xD.

Automatic segmentation of cervical tumors is important in quantitative analysis and radiotherapy planning. A parallel encoder U-Net (PEU-Net) integrating the multi-modality information of PET/MRI was proposed to segment cervical tumor, which consisted of two parallel encoders with the same structure for PET and MR images. The features of the two modalities were extracted separately and fused at each layer of the decoder. Res2Net module on skip connection aggregated the features of various scales and refined the segmentation performance. PET/MRI images of 165 patients with cervical cancer were included in this study. U-Net, TransUNet, and nnU-Net with single or multi-modality (PET or/and T2WI) input were used for comparison. The Dice similarity coefficient (DSC) with volume data, DSC and the 95th percentile of Hausdorff distance (HD95) with tumor slices were calculated to evaluate the performance. The proposed PEU-Net exhibited the best performance (DSC_3d: 0.726 ± 0.204, HD₉₅: 4.603 ± 4.579 mm), DSC_2d (0.871 ± 0.113) was comparable to the best result of TransUNet with PET/MRI (0.873 ± 0.125). The networks with multi-modality input outperformed those with single-modality images as input. The results showed that the proposed PEU-Net could use multi-modality information more effectively through the redesigned structure and achieved competitive performance.